LMO1 and neuroblastoma: The current results implied that rs2168101 GT/TT genotypes in the LMO1 gene were found to decrease the risk of developing Wilms tumor in the dominant model (adjusted OR = 0.74, 95% CI = 0.59–0.93, P = 0.009), which is consistent with the tendency for neuroblastoma and Wilms tumor in previous studies [27, 39, 40].